Efficacy Study of Leflunomide to Treat Juvenile Idiopathic Arthritis
Status:
Unknown status
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
A randomized double blind clinical trial to assess efficacy of leflunomide in treatment of
refractory juvenile idiopathic arthritis.
Patients are randomly divided into two groups. In group 1 leflunomide and in group 2 placebos
will be added to conventional treatment for three months. therapeutic responses will be
evaluated by ACRpedi (American College of Rheumatology Pediatric) scores every 4 weeks.